{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T01:10:31Z","timestamp":1692493831808},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1981,1,1]],"date-time":"1981-01-01T00:00:00Z","timestamp":347155200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1981]]},"DOI":"10.1007\/bf00542103","type":"journal-article","created":{"date-parts":[[2004,11,18]],"date-time":"2004-11-18T17:43:22Z","timestamp":1100799802000},"page":"479-483","source":"Crossref","is-referenced-by-count":15,"title":["Pharmacokinetic study of chloramphenicol in patients with liver disease"],"prefix":"10.1007","volume":"20","author":[{"given":"A. P. S.","family":"Narang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. V.","family":"Datta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Nath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. S.","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"411","volume":"23","author":"AJ Glazko","year":"1949","unstructured":"Glazko AJ, Wolf LM, Dill WA (1949) Biochemical studies on chloramphenicol (chloromycetin). I. Colorimetric methods for the determination of chloramphenicol and related compounds. Arch Biochem 23: 411?418","journal-title":"Arch Biochem"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3181\/00379727-68-16377","volume":"68","author":"HL Ley Jr.","year":"1948","unstructured":"Ley HL, Jr., Smadel JE, Crocker TT (1948) Administration of chloromycetin to normal human subjects. Proc Soc Exp Biol 68: 9?12","journal-title":"Proc Soc Exp Biol"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/0006-2952(73)90222-0","volume":"22","author":"JA Smith","year":"1973","unstructured":"Smith JA, Butler TC, Poole DT (1973) Effect of protein depletion in guinea pigs on glucuronate conjugation of chloramphenicol by liver microsomes. Biochem Pharmacol 22: 981?983","journal-title":"Biochem Pharmacol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/ajcn\/28.9.977","volume":"28","author":"S Mehta","year":"1975","unstructured":"Mehta S, Kalsi HK, Jayaraman S, Mathur VS (1975) Chloramphenicol metabolism in children with protein ? calorie malnutrition. Am J Clin Nutr 28: 977?981","journal-title":"Am J Clin Nutr"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1172\/JCI103928","volume":"38","author":"CM Kunin","year":"1959","unstructured":"Kunin CM, Glazko AJ, Finland M (1959) Persistance of antibiotic with acute renal failure. II. Chloramphenicol and its metabolic products in the blood of patients with severe renal disease or hepatic cirrhosis. J Clin Invest 38: 1498?1508","journal-title":"J Clin Invest"},{"key":"CR6","first-page":"130","volume":"6","author":"F Azzollini","year":"1972","unstructured":"Azzollini F, Gazzaniga A, Lodola E, Natangelo R (1972) Elimination of chloramphenicol and thiamphenicol in subjects with cirrhosis of the liver. Int. J Clin Pharmacol 6: 130?134","journal-title":"Int. J Clin Pharmacol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/archinte.1963.03860050134016","volume":"112","author":"LG Shurland","year":"1963","unstructured":"Shurland LG, Weisberger AL (1963) Chloramphenicol toxicity in liver and renal disease. Arch Intern Med 112: 747?754","journal-title":"Arch Intern Med"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1056\/NEJM196907032810110","volume":"281","author":"W Dameshek","year":"1969","unstructured":"Dameshek W (1969) Chloramphenicol aplastic anemia in identical twins. A clue to pathogenesis. N Engl J Med 281: 42?43","journal-title":"N Engl J Med"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/cpt1970112194","volume":"11","author":"PH Levine","year":"1970","unstructured":"Levine PH, Regelson W, Holland JF (1970) Chloramphenicol associate encephalopathy. Clin Pharmacol Ther 11: 194?199","journal-title":"Clin Pharmacol Ther"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/adc.49.3.235","volume":"49","author":"AW Craft","year":"1974","unstructured":"Craft AW, Brocklebank JT, Hay EN, Jackson RH (1974) The ?grey todder? chloramphenicol toxicity. Arch Dis Childh 49: 235?237","journal-title":"Arch Dis Childh"},{"key":"CR11","first-page":"59","volume":"38","author":"J Levine","year":"1951","unstructured":"Levine J, Fischback H (1951) The chemical determination of chloramphenicol in biological materials. Antibio Chemother 38: 59?65","journal-title":"Antibio Chemother"},{"key":"CR12","volume-title":"Biopharmaceutics and Pharmacokinetics. An introduction","author":"RE Notari","year":"1975","unstructured":"Notari RE, DeYoung JL, Anderson RC (1975) Biopharmaceutics and Pharmacokinetics. An introduction. 2nd edit. Marcel Dekker, New York","edition":"2nd edit."},{"key":"CR13","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/bmj.2.5516.724","volume":"2","author":"AA Lindberg","year":"1966","unstructured":"Lindberg AA, Nilsson LH, Bucht H, Kallings, LO (1966) Concentration of chloramphenicol in the urine and blood in relation to renal function. Br Med J 2: 724?728","journal-title":"Br Med J"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000136497","volume":"11","author":"A Watanabe","year":"1974","unstructured":"Watanabe A (1974) Effect of chronic administration of centrally acting compounds on chloramphenicol metabolism in schizophrenic patients. Pharmacol 11: 253?256","journal-title":"Pharmacol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(68)92292-7","volume":"1","author":"AJ Levy","year":"1968","unstructured":"Levy AJ, Sherlock S, Walker D (1968) Phenylbutazone and isosiazid metabolism in patients with liver disease in relation to previous durg therapy. Lancet 1: 1275?1279","journal-title":"Lancet"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0002-9343(70)80129-2","volume":"49","author":"H Remmer","year":"1970","unstructured":"Remmer H (1970) The Role of the liver in drug metabolism. Am J Med 49: 617?629","journal-title":"Am J Med"},{"key":"CR17","first-page":"511","volume":"24","author":"DV Datta","year":"1976","unstructured":"Datta, DV (1976) Review: Non-cirrhotic portal fibrosis (Idiopathic portal hypertension) in India. J Assoc Phys India 24: 511?527","journal-title":"J Assoc Phys India"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/BF01070884","volume":"20","author":"DV Datta","year":"1975","unstructured":"Datta DV, Nair R, Nair CR (1975): Estimation of hepatic bilirubin UDP-glucuronyl transferase in patients with noncirrhotic portal fibrosis and liver disease. Significance and limitations. Am J Dig Dis 20: 961?971","journal-title":"Am J Dig Dis"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00542103.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00542103\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00542103","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T22:34:11Z","timestamp":1554417251000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00542103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1981]]}},"alternative-id":["BF00542103"],"URL":"https:\/\/doi.org\/10.1007\/bf00542103","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1981]]}}}